Chiu C-H, Lin Y-J, Ramesh S, Kuo W-W, Chen M-C, Kuo C-H, Li C-C, Wang T-F, Lin Y-M, Liao P-H, et al. Gemcitabine resistance in non-small cell lung cancer is mediated through activation of the PI3K/AKT/NF-κB pathway and suppression of ERK signaling by reactive oxygen species. J Biochem Mol Toxicol. 2023:e23497.